Gainers
- InnSuites Hospitality Trust IHT shares jumped 77% to $4.321.
- Regional Health Properties, Inc. RHE gained 43% to $21.40 after dropping 23% on Thursday.
- Auris Medical Holding Ltd. EARS jumped 31% to $3.77 after the company issued an update on Bentrio program in allergy.
- Avalon Holdings Corporation AWX gained 28% to $5.32.
- LM Funding America, Inc. LMFA shares climbed 27.6% to $4.8450. The company announced a 1-for-5 reverse stock split effective May 7.
- Pro-Dex, Inc. PDEX gained 23% to $36.08 after reporting a rise in quarterly earnings.
- Yield10 Bioscience, Inc. YTEN surged 20.4% to $10.33.
- Epizyme, Inc. EPZM climbed 19.3% to $8.13 after SVB Leerink upgraded the stock from Market Perform to Outperform and raised its price target from $12 to $16per share.
- iBio, Inc. IBIO rose 18.5% to $1.6350 after the company provided an update on its IBIO-201 program and reported on its progress in developing a second-generation subunit vaccine candidate, IBIO-202, being designed for the prevention of SARS-CoV-2 infection.
- Cyclerion Therapeutics, Inc. CYCN shares rose 18.1% to $2.9403.
- Recro Pharma, Inc. REPH gained 18% to $2.9605 following strong Q1 results.
- Core Molding Technologies, Inc. CMT jumped 17.9% to $13.35 after the company reported higher Q1 earnings.
- Cooper-Standard Holdings Inc. CPS surged 17.3% to $33.55 following strong quarterly sales.
- Tilray, Inc. TLRY gained 16.3% to $16.46 after Jefferies upgraded the stock from Underperform to Buy and raised its price target from $4.77 to $23 per share.
- Golden Entertainment, Inc. GDEN jumped 15.1% to $41.16 after the company reported better-than-expected Q1 sales results.
- GoPro, Inc. GPROshares rose 14.9% to $11.99 after the company swung to a Q1 profit.
- Bill.com Holdings, Inc. BILL gained 14.7% to $149.26 after the company reported better-than-expected Q3 results and issued strong Q4 guidance.
- InspireMD, Inc. NSPR gained 14.7% to $5.60.
- Roku, Inc. ROKU shares rose 14.7% to $325.88 after the company reported better-than-expected Q1 results and issued strong Q2 revenue guidance.
- MEDNAX, Inc. MD surged 14.5% to $30.65 after the company reported better-than-expected Q1 results.
- Diana Shipping Inc. DSX rose 14.1% to $4.2450 after the company reported a time chart contract for m/v Myrsini with Bocimar.
- Qurate Retail, Inc. QRTEA gained 13.6% to $13.43 following upbeat quarterly results.
- Tabula Rasa HealthCare, Inc. TRHC jumped 13.1% to $48.28 after reporting Q1 results.
- Assertio Holdings, Inc. ASRT shares rose 12.2% to $0.5599 after the company reported better-than-expected Q1 results.
- Nikola Corporation NKLA gained 12% to $11.35 after the cpmpany posted a narrower-than-expected quarterly loss.
- ADTRAN, Inc. ADTN jumped 10.8% to $19.49. The company recently released Q1 results.
- Evofem Biosciences, Inc. EVFM rose 9.8% to $1.34 after reporting Q1 results.
- Expedia Group, Inc. EXPE rose 8.8% to $179.37 after the company reported better-than-expected Q1 results.
- Datadog, Inc. DDOG rose 8.2% to $77.16 after the company reported better-than-expected Q1 results and issued sales guidance above estimates.
- CureVac N.V. CVAC rose 8.2% to $101.61 after dropping over 7% on Thursday.
- T2 Biosystems, Inc. TTOO rose 6.1% to $1.23 after the company reported better-than-expected Q1 sales. The company also modified terms of existing contract with Biomedical Advanced Research and Development Authority (BARDA) to accelerate development of multiple products being funded under contract.
- Cloudflare, Inc. NET shares rose 6% to $73.11 after the company reported better-than-expected Q1 sales results and issued strong sales guidance.
- Groupon, Inc. GRPN shares rose 5.8% to $51.76 after the company reported better-than-expected Q1 sales results and raised FY21 guidance.
- Peloton Interactive, Inc. PTON rose 5.3% to $88.20 following strong quarterly results.
Check out these big penny stock gainers and losers
Losers
- ChemoCentryx, Inc. CCXI shares dipped 60% to $11.00 after the company said the FDA's Arthritis Advisory Committee that evaluated avacopan for the treatment of antineutrophil cytoplasmic autoantibody-associated vasculitis gave a split verdict on whether the efficacy data support approval of avacopan. The committee voted 9-7 in favor of safety and 10-8 that the benefit-risk profile is adequate to support approval of avacopan at the proposed dose of 30 mg twice daily.
- Centerra Gold Inc. CGAU fell 30.5% to $6.85.
- Orphazyme A/S ORPH fell 29.3% to $6.00 after the company announced that the ORARIALS-01 pivotal trial of arimoclomol in amyotrophic lateral sclerosis (ALS) did not meet its primary and secondary endpoints.
- F-star Therapeutics, Inc. FSTX dipped 21% to $7.00 after the company priced its 9.29 million shares common stock offering at $7 per share.
- Charles & Colvard, Ltd. CTHR dropped 18.2% to $2.68 after the company reported Q3 earnings results.
- Stealth BioTherapeutics Corp MITO fell 18% to $1.33. Stealth BioTherapeutics shares jumped 35% on Thursday in reaction to new data from a post hoc analysis of Phase 1 ReCLAIM study evaluating elamipretide in patients with noncentral geographic atrophy (GA) and high-risk drusen associated with dry age-related macular degeneration (AMD).
- Natural Grocers by Vitamin Cottage, Inc. NGVC dropped 16.6% to $13.29 after the company reported a decline in quarterly earnings.
- Alfi, Inc. ALF dipped 16.1% to $3.03.
- Aurinia Pharmaceuticals Inc. AUPH fell 15.8% to $10.38 after the company reported a wider Q1 loss.
- JFrog Ltd. FROG fell 15.6% to $35.55 after the company reported Q1 earnings results.
- Waitr Holdings Inc. WTRH dropped 15% to $2.065 after the company reported worse-than-expected Q1 earnings.
- ShiftPixy, Inc. PIXY shares fell 14.7% to $2.57 after jumping 25% on Thursday.
- Drive Shack Inc. DS dropped 14% to $2.925 after reporting a Q1 loss.
- Shake Shack Inc. SHAK fell 13.6% to $91.40 after the company reported downbeat Q1 sales and issued weak Q2 sales guidance.
- Gannett Co., Inc. GCI dropped 12.8% to $3.9199 after reporting a wider quarterly loss.
- Teradata Corporation TDC fell 11.3% to $42.95 after the company issued weak FY21 earnings forecast.
- Farmer Bros. Co. FARM dipped 11.1% to $9.25 after the company reported worse-than-expected Q3 results.
- Installed Building Products, Inc. IBP fell 11.1% to $122.60 after the company reported worse-than-expected Q1 results.
- Global Partners LP GLP shares declined 10.3% to $23.44 after the company reported worse-than-expected Q1 earnings.
- Johnson Outdoors Inc. JOUT dropped 7.9% to $132.85 following Q2 results.
- TrueCar, Inc. TRUE fell 6.8% to $4.4550 following Q1 results.
- Monster Beverage Corporation MNST fell 5.7% to $89.57 after the company reported worse-than-expected Q1 EPS results.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in